A multi-center, single-arm, phase II study of anlotinib plus paclitaxel and cisplatin as the first-line therapy of recurrent/advanced esophageal squamous cell carcinoma - Concepedia

Concepedia

Publication | Open Access

A multi-center, single-arm, phase II study of anlotinib plus paclitaxel and cisplatin as the first-line therapy of recurrent/advanced esophageal squamous cell carcinoma

DOI Full Paper Access

13

Citations

34

References

2022

Year

Ning Li, Tao Wu, Yonggui Hong, Yanzhen Guo, Yufeng Cheng, Yi-Jie Ma, Liangyu Bie, Donghai Cui, Xiaohui Gao, Bingxu Tan,

Abstract

ClinicalTrials.gov NCT04063683. Registered 21 August 2019.

References

	Year	Citations

Page 1